Pharmacists of St. Petersburg Gathered in EXPOFORUM

On October 17 specialists spoke on relevant issues of pharmacy at the St. Petersburg Health Forum.

The most difficult questions pharmacists face today in their practice are the delivery of medicinal drugs and the responsibility of a pharmaceutical professional for released drugs. Participants of the conference think that they face these problems the most often.

One of the speakers, Nina Zabalueva, Candidate of Chemistry, Council Member of the NGO St Petersburg Professional Association of pharmacists (PAFR), reminded her colleagues that their activities are regulated by law. “For example, Russian Federation Law №61-FZ and, particularly, Article 68, states that violation of the legislation of the Russian Federation for medicines circulation shall be punishable under criminal law. We also have secondary legislation and various penalties. Penalties for causing harm as a result of delivery of a low-quality drug or insufficient consultation are assigned to a separate group,” Nina Ivanovna explained.

In her report the speaker examined the legal responsibility of a pharmaceutical professional in detail, and reminded her colleagues that they bear two kinds of responsibility - material and civil. As for consistent violations that are commonly found in practice, Nina Zabalueva noted the following: a disregard of rules of the delivery and release of drugs, a lack of internal quality control of providing services, and violations of drug storage and period of validity.

The next report, presented by Elena Obraztsova, Candidate of Medicine, employee of FSBE Smorodintsev Research Institute of Influenza (Russian Ministry of Health), was dedicated to treatment of influenza complications and acute respiratory viral infection (ARVI). As the speaker noted, influenza and ARVI make up 90% of all infectious diseases among children and 65% of all registered diseases. They cause 86% of the economic damage of all infections.

“There are several kinds of drugs for the treatment of influenza and ARVI: etiotropic (antivirals and antimicrobial drugs), syndromic or pathogenic (symptomatic) and immune rehabilitating drugs,” the speaker said. “The latter are most often assigned for prolonged treatment of people with a dysfunctional premorbid background.”

More

Pharmacists of St. Petersburg Gathered in EXPOFORUM

On October 17 specialists spoke on relevant issues of pharmacy at the St. Petersburg Health Forum.

The most difficult questions pharmacists face today in their practice are the delivery of medicinal drugs and the responsibility of a pharmaceutical professional for released drugs. Participants of the conference think that they face these problems the most often.

One of the speakers, Nina Zabalueva, Candidate of Chemistry, Council Member of the NGO St Petersburg Professional Association of pharmacists (PAFR), reminded her colleagues that their activities are regulated by law. “For example, Russian Federation Law №61-FZ and, particularly, Article 68, states that violation of the legislation of the Russian Federation for medicines circulation shall be punishable under criminal law. We also have secondary legislation and various penalties. Penalties for causing harm as a result of delivery of a low-quality drug or insufficient consultation are assigned to a separate group,” Nina Ivanovna explained.

In her report the speaker examined the legal responsibility of a pharmaceutical professional in detail, and reminded her colleagues that they bear two kinds of responsibility - material and civil. As for consistent violations that are commonly found in practice, Nina Zabalueva noted the following: a disregard of rules of the delivery and release of drugs, a lack of internal quality control of providing services, and violations of drug storage and period of validity.

The next report, presented by Elena Obraztsova, Candidate of Medicine, employee of FSBE Smorodintsev Research Institute of Influenza (Russian Ministry of Health), was dedicated to treatment of influenza complications and acute respiratory viral infection (ARVI). As the speaker noted, influenza and ARVI make up 90% of all infectious diseases among children and 65% of all registered diseases. They cause 86% of the economic damage of all infections.

“There are several kinds of drugs for the treatment of influenza and ARVI: etiotropic (antivirals and antimicrobial drugs), syndromic or pathogenic (symptomatic) and immune rehabilitating drugs,” the speaker said. “The latter are most often assigned for prolonged treatment of people with a dysfunctional premorbid background.”

More